Harmony Biosciences Holdings Financial Overview
Harmony Biosciences Holdings's market cap is currently $2.24B. The company's EPS TTM is $0.87; its P/E ratio is 12.21; Harmony Biosciences Holdings is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $0.85. See an overview of income statement, balance sheet, and cash flow financials.
